Nautilus Biotechnolgy
NAUT
NAUT
56 hedge funds and large institutions have $380M invested in Nautilus Biotechnolgy in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
27% more funds holding
Funds holding: 44 → 56 (+12)
18% more call options, than puts
Call options by funds: $294K | Put options by funds: $250K
46.2% less ownership
Funds ownership: 77.66% → 31.46% (-46%)
Holders
56
Holding in Top 10
3
Calls
$294K
Puts
$250K
Top Buyers
| 1 | +$90M | |
| 2 | +$47.8M | |
| 3 | +$22.5M | |
| 4 |
ABG
Ally Bridge Group
New York
|
+$15.2M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$15.1M |
Top Sellers
| 1 | -$8.39M | |
| 2 | -$7.78M | |
| 3 | -$5.77M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.17M |
| 5 |
ESCM
Echo Street Capital Management
New York
|
-$3.95M |